Locations:
SearchFrom amyloidosis to small cell bladder cancer
Rare cancers are often diagnosed at later stages, and overall survival is poor. A large, academic, tertiary referral center like Cleveland Clinic Cancer Center offers patients the collective expertise of dozens of specialists who study, diagnose and treat uncommon diseases on a regular basis. Learn more about the depth and breadth of our experience below.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients